Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Angermann CE"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 40
Tytuł:
Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach.
Autorzy:
de Gonzalo-Calvo D; Translational Research in Respiratory Medicine, IRBLleida, University Hospital Arnau de Vilanova and Santa Maria, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Martinez-Camblor P; Anesthesiology Department, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.; Faculty of Health Sciences, Universidad Autonoma de Chile, Providencia, Chile.
Belmonte T; Translational Research in Respiratory Medicine, IRBLleida, University Hospital Arnau de Vilanova and Santa Maria, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Barbé F; Translational Research in Respiratory Medicine, IRBLleida, University Hospital Arnau de Vilanova and Santa Maria, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
Duarte K; INSERM 1433, CHRU de Nancy, Centre d'Investigations Cliniques Plurithématique, Institut Lorrain du Cœur et des Vaisseaux, Université de Lorraine, Nancy, France.
Cowie MR; Department of Cardiology, Royal Brompton Hospital (Guy's & St Thomas's NHS Foundation Trust), London, UK.
Angermann CE; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.; Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.
Korte A; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Riedel I; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Labus J; Cellular Neurophysiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Koenig W; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.; German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.; Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
Zannad F; Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 1433, Inserm U1116, CHRU Nancy, F-CRIN INI-CRCT Network, Nancy, France.
Thum T; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. .; Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Nikolai-Fuchs-Str. 1, 30625, Hannover, Germany. .
Bär C; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. .; Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Nikolai-Fuchs-Str. 1, 30625, Hannover, Germany. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Oct 20; Vol. 21 (1), pp. 742. Date of Electronic Publication: 2023 Oct 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*
Sleep Apnea, Central*/complications
MicroRNAs*/genetics
Ventricular Dysfunction, Left*
Humans ; Biomarkers ; Stroke Volume ; Decision Trees
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF.
Autorzy:
Ouwerkerk W; National Heart Centre Singapore, Singapore.; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
Tromp J; Duke-National University of Singapore, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
Cleland JGF; Robertson Centre for Biostatistics and Clinical Trials, Institute of Health & Well-Being, University of Glasgow and National Heart & Lung Institute, Imperial College, London, UK.
Angermann CE; University and University Hospital Würzburg, Comprehensive Heart Failure Center, Würzburg, Germany.
Dahlstrom U; Department of Cardiology and Department of Health, Medicine and Caring Sciences, Linkoping University, Linkoping, Sweden.
Ertl G; University and University Hospital Würzburg, Comprehensive Heart Failure Center, Würzburg, Germany.
Hassanein M; Department of Cardiology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Perrone SV; El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute, Sanctuary of the Trinidad Miter, Buenos Aires, Argentina.
Ghadanfar M; M-Ghadanfar Consulting (Life Sciences), Basel, Switzerland.
Schweizer A; Novartis Pharma AG, Basel, Switzerland.
Obergfell A; Novartis Pharma AG, Basel, Switzerland.
Dickstein K; University of Bergen, Stavanger University Hospital, Stavanger, Norway.
Filippatos G; School of Medicine, Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Collins SP; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Lam CSP; National Heart Centre Singapore, Singapore.; Duke-National University of Singapore, Singapore.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2023 Jan; Vol. 25 (1), pp. 43-51. Date of Electronic Publication: 2022 Nov 23.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Furosemide*
Heart Failure*
Female ; Humans ; Aftercare ; Diuretics/therapeutic use ; Patient Discharge ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of remote haemodynamic-guided heart failure management in patients with different subtypes of pulmonary hypertension: insights from the MEMS-HF study.
Autorzy:
Assmus B; Cardiology, Department of Medicine, Goethe University Hospital, Frankfurt, Germany.; Medical Clinic I, Department of Cardiology, University Hospital Giessen, Justus Liebig University Giessen, Giessen, Germany.
Angermann CE; Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.
Alkhlout B; Klinikum Karlsburg, Heart and Diabetes Center Mecklenburg-Western Pommerania, Karlsburg, Germany.
Asselbergs FW; Division Heart & Lungs, Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Schnupp S; Medical Centre Coburg GmbH II, Medical Clinic Cardiology, Angiology, Pulmonology, Coburg, Germany.
Brugts JJ; Thorax Center, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Nordbeck P; Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.; Cardiology, Department of Medicine I, Centre for Internal Medicine, University Hospital Würzburg, Würzburg, Germany.
Zhou Q; Department of Cardiology and Angiology I, University Heart Center Freiburg, University of Freiburg, Bad Krozingen, Germany.
Brett ME; Abbott, Sylmar, Sylmar, CA, USA.
Ginn G; Abbott, Sylmar, Sylmar, CA, USA.
Adamson PB; Abbott, Sylmar, Sylmar, CA, USA.
Böhm M; Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Homburg, Germany.
Rosenkranz S; Clinic III for Internal Medicine, and Cologne Cardiovascular Research Center (CCRC), University of Cologne Heart Center, Köln, Germany.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Dec; Vol. 24 (12), pp. 2320-2330. Date of Electronic Publication: 2022 Nov 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hypertension, Pulmonary*/therapy
Heart Failure*/diagnosis
Micro-Electrical-Mechanical Systems*
Humans ; Quality of Life ; Hemodynamics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial.
Autorzy:
Voors AA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Damman K; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, CA, USA.
Angermann CE; Comprehensive Heart Failure Centre, University & University Hospital of Würzburg, Würzburg, Germany.
Collins SP; Department of Emergency Medicine, Vanderbilt University Medical Center and Geriatric Research and Education Clinical Care, Tennessee Valley Healthcare Facility VA Medical Center, Nashville, TN, USA.
Kosiborod M; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, MS, USA.; The George Institute for Global Health and The University of New South Wales, Sydney, NSW, Australia.
Biegus J; Institute of Heart Diseases, Medical University, Wroclaw, Poland.
Ferreira JP; Inserm INI-CRCT, CHRU, Université de Lorraine, Nancy, France.; Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal.
Nassif ME; Saint Luke's Mid America Heart Institute and the University of Missouri, Kansas City, MS, USA.
Psotka MA; Inova Heart and Vascular Institute, Falls Church, VA, USA.
Tromp J; Saw Swee Hock School of Public Health, National University of Singapore, and the National University Health System, Singapore.
Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim, Germany.; First Department of Medicine faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
Blatchford JP; Elderbrook Solutions GmbH on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Salsali A; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.; Faculty of Medicine, Rutgers University, New Brunswick, NJ, USA.
Ponikowski P; Institute of Heart Diseases, Medical University, Wroclaw, Poland.
Pokaż więcej
Corporate Authors:
EMPULSE Trial Investigators
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1844-1852. Date of Electronic Publication: 2022 Sep 27.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Sodium-Glucose Transporter 2 Inhibitors*/pharmacology
Diabetes Mellitus, Type 2*/drug therapy
Heart Failure*
Humans ; Quality of Life ; Kidney ; Hospitalization
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).
Autorzy:
McNaughton CD; ICES, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.; Vanderbilt University Medical Center, Nashville, TN, USA.
McConnachie A; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Cleland JG; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Spertus JA; Saint Luke's Mid America Heart Institute/University of Missouri -, Kansas City, MO, USA.
Angermann CE; Comprehensive Heart Failure Center, University Hospital, Department of Medicine-Cardiology University of Würzburg, Würzburg, Germany.
Duklas P; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Tromp J; Saw Swee Hock School of Public Health, National University of Singapore, The National University Health System, Singapore.
Lam CSP; National Heart Centre Singapore, Singapore; Cardiovascular Academic Clinical Program, Duke-National University of Singapore, Singapore.
Filippatos G; University of Cyprus School of Medicine, Cyprus, Greece.
Dahlstrom U; Department of Cardiology and Department of Health, Medicine and Caring Sciences, Linkoping University, Linkoping, Sweden.
Dickstein K; University of Bergen, Stavanger University Hospital, Stavanger, Norway.
Schweizer A; Novartis Pharma AG, Basel, Switzerland.
Perrone SV; Hospital El Cruce Hospital Florencio Varela; FLENI Institute and Argentine Institute of Diagnosis and Treatment, Argentine Catholic University, Buenos Aires, Argentina.
Hassanein M; Alexandria University, Alexandria, Egypt.
Ertl G; Comprehensive Heart Failure Center, University Hospital, Department of Medicine-Cardiology University of Würzburg, Würzburg, Germany.
Obergfell A; Vifor Pharma AG, Glattbrugg, Switzerland.
Ghadanfar M; M-Ghadanfar Consulting (Life Sciences), Basel, Switzerland.
Collins SP; Vanderbilt University Medical Center, Nashville, TN, USA.; Geriatric Research and Education Clinical Care, Tennessee Valley Healthcare Facility VA Medical Center, Nashville, TN, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Jun; Vol. 24 (6), pp. 1020-1029. Date of Electronic Publication: 2022 May 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*/drug therapy
Heart Failure*/therapy
Quality of Life*
Aged ; Female ; Health Status ; Hospitalization ; Humans ; Male ; Registries ; Stroke Volume ; United States/epidemiology ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry.
Autorzy:
Tromp J; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.; Duke-NUS Medical School, Singapore.
Beusekamp JC; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Ouwerkerk W; National Heart Centre Singapore, Singapore.; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
van der Meer P; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Cleland JGF; Robertson Centre for Biostatistics and Clinical Trials, Institute of Health & Well-Being, University of Glasgow and National Heart & Lung Institute, Imperial College, London, UK.
Angermann CE; Comprehensive Heart Failure Centre, University Hospital and University of Würzburg, Würzburg, Germany.
Dahlstrom U; Department of Cardiology and Department of Health, Medicine and Caring Sciences, Linkoping University, Linkoping, Sweden.
Ertl G; Comprehensive Heart Failure Centre, University Hospital and University of Würzburg, Würzburg, Germany.
Hassanein M; Alexandria University, Faculty of Medicine, Cardiology Department Alexandria, Egypt.
Perrone SV; El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute, Sanctuary of the Trinidad Miter, Buenos Aires, Argentina.
Ghadanfar M; M-Ghadanfar Consulting (Life Sciences), Basel, Switzerland.
Schweizer A; Novartis Pharma AG, Basel, Switzerland.
Obergfell A; Novartis Pharma AG, Basel, Switzerland.
Filippatos G; University of Cyprus, School of Medicine & National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece.
Dickstein K; University of Bergen, Stavanger University Hospital, Norway.
Collins SP; Vanderbilt University Medical Center and Veterans Affairs Tennessee Valley Healthcare System, Geriatric Research, Education and Clinical Center (GRECC), Department of Emergency Medicine, Nashville, Tennessee, USA.
Lam CSP; Duke-NUS Medical School, Singapore.; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; National Heart Centre Singapore, Singapore.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Apr; Vol. 24 (4), pp. 645-652. Date of Electronic Publication: 2022 Feb 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*/epidemiology
Heart Failure*/therapy
Hypertension*
Aftercare ; Aged ; Female ; Hospitalization ; Humans ; Male ; Middle Aged ; Patient Discharge ; Precipitating Factors ; Prognosis ; Prospective Studies ; Registries ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial.
Autorzy:
Tromp J; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Duke-NUS Medical School, Singapore.; National Heart Centre Singapore, Singapore.
Ponikowski P; Department of Heart Diseases, Medical University, Wroclaw, Poland.
Salsali A; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.; Faculty of Medicine, Rutgers University, New Brunswick, NJ, USA.
Angermann CE; Comprehensive Heart Failure Center, University and University Hospital, Würzburg, University Hospital Würzburg, Würzburg, Germany.
Biegus J; Department of Heart Diseases, Medical University, Wroclaw, Poland.
Blatchford J; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
Collins SP; Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Ferreira JP; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Grauer C; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
Kosiborod M; Saint Luke's Mid America Heart Institute and the University of Missouri, Kansas City, MO, USA.; The George Institute for Global Health and the University of New South Wales, Sydney, NSW, Australia.
Nassif ME; Saint Luke's Mid America Heart Institute and the University of Missouri, Kansas City, MO, USA.
Psotka MA; Inova Heart and Vascular Institute, Falls Church, VA, USA.
Brueckmann M; Boehringer Ingelheim International GmbH, Ingelheim, Germany.; Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Voors AA; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 May; Vol. 23 (5), pp. 826-834. Date of Electronic Publication: 2021 Mar 10.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*
Asia ; Europe ; Glucose ; Humans ; North America ; Sodium ; Sodium-Glucose Transporter 2 ; Stroke Volume
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF).
Autorzy:
Angermann CE; Comprehensive Heart Failure Center, University and University Hospital, Würzburg, University Hospital Würzburg, Würzburg, Germany.
Assmus B; Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany.; Department of Medicine I, Cardiology/Angiology, University Hospital, Giessen, Germany.
Anker SD; Division of Cardiology & Metabolism and Department of Cardiology & Berlin-Brandenburg Center for Regenerative Therapies, and German Center for Cardiovascular Research, partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
Asselbergs FW; Division Heart & Lungs, Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Brachmann J; Medical Centre Coburg GmbH II, Medical Clinic Cardiology, Angiology, Pulmonology, Coburg, Germany.
Brett ME; Abbott, Sylmar, CA, USA.
Brugts JJ; Erasmus MC University Medical Centre, Thoraxcenter, Rotterdam, The Netherlands.
Ertl G; Comprehensive Heart Failure Center, University and University Hospital, Würzburg, University Hospital Würzburg, Würzburg, Germany.
Ginn G; Abbott, Sylmar, CA, USA.
Hilker L; Klinikum Karlsburg, Heart and Diabetes Center Mecklenburg-Western Pommerania, Karlsburg, Germany.
Koehler F; Division of Cardiology and Angiology, Medical Department, Campus Charité Mitte, Centre for Cardiovascular Telemedicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
Rosenkranz S; Clinic III for Internal Medicine, University of Cologne Heart Center, and Cologne Cardiovascular Research Center (CCRC), Cologne, Germany.
Zhou Q; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.; Department of Cardiology, University Hospital Basel, Basel, Switzerland.
Adamson PB; Abbott, Sylmar, CA, USA.
Böhm M; Internal Medicine III Cardiology, Angiology, Intensive Care, Saarland University Medical Centre, Homburg, Germany.
Pokaż więcej
Corporate Authors:
MEMS-HF Investigators
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Oct; Vol. 22 (10), pp. 1891-1901. Date of Electronic Publication: 2020 Aug 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*/epidemiology
Heart Failure*/therapy
Micro-Electrical-Mechanical Systems*
Aged ; Female ; Germany ; Humans ; Ireland ; Male ; Middle Aged ; Netherlands ; Pulmonary Artery ; Quality of Life ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
Autorzy:
Morbach C; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.; Department of Medicine I, Cardiology, University Hospital Würzburg, Würzburg, Germany.
Marx A; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.
Kaspar M; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.
Güder G; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.; Department of Medicine I, Cardiology, University Hospital Würzburg, Würzburg, Germany.
Brenner S; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.; Department of Medicine I, Cardiology, University Hospital Würzburg, Würzburg, Germany.
Feldmann C; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.; Department of Medicine I, Cardiology, University Hospital Würzburg, Würzburg, Germany.
Störk S; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.; Department of Medicine I, Cardiology, University Hospital Würzburg, Würzburg, Germany.
Vollert JO; Thermo Fisher Scientific, Henningsdorf, Germany.
Ertl G; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.; Department of Medicine I, Cardiology, University Hospital Würzburg, Würzburg, Germany.
Angermann CE; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.; Department of Medicine I, Cardiology, University Hospital Würzburg, Würzburg, Germany.
Pokaż więcej
Corporate Authors:
INH Study Group and the Competence Network Heart Failure
Źródło:
European journal of heart failure [Eur J Heart Fail] 2017 Sep; Vol. 19 (9), pp. 1166-1175. Date of Electronic Publication: 2017 May 17.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*/diagnosis
Heart Failure*/drug therapy
Adrenomedullin/*analysis
Natriuretic Peptide, Brain/*analysis
Peptide Fragments/*analysis
Aged ; Biomarkers/analysis ; Female ; Follow-Up Studies ; Germany ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Risk Assessment/methods ; Statistics as Topic ; Ventricular Function, Left/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 40

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies